Projects per year
Personal profile
Education
- 2011 PhD, Institute of Clinical Pharmacy and Pharmaceutical Sciences , National Cheng Kung University
Experience
- 2011-2012, Postdoctoral Fellow/Department of Biochemistry and Molecular Biology, National Cheng Kung University
- 2012-present, Research Fellow/Antibody New Drug Development Center, National Cheng Kung University
- 2013-2015, Adjunct Assistant Professor/Department of Biochemistry and Molecular Biology, National Cheng Kung University
- 2015-present, Assistant Professor/Institute of Clinical Medicine, National Cheng Kung University
Research Interests
- Cytokine regulation
- Osteoimmunology
- New antibody drug development
Fingerprint Dive into the research topics where Yu-Hsiang Hsu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 10 Similar Profiles
Interleukins
Medicine & Life Sciences
Monoclonal Antibodies
Medicine & Life Sciences
Experimental Arthritis
Medicine & Life Sciences
Rheumatoid Arthritis
Medicine & Life Sciences
Osteolysis
Medicine & Life Sciences
interleukin 20
Medicine & Life Sciences
Cytokines
Medicine & Life Sciences
Bone Neoplasms
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2006 2018
1
Citation
(Scopus)
IL-20 bone diseases involvement and therapeutic target potential
Wang, H. H., Hsu, Y-H. & Chang, M-S., 2018 Apr 24, In : Journal of biomedical science. 25, 1, 38.Research output: Contribution to journal › Review article
Bone Diseases
Bone
Bone and Bones
Osteolysis
Osteogenesis
The roles of IL-19 and IL-20 in the inflammation of degenerative lumbar spondylolisthesis
Huang, K., Hsu, Y., Chen, W., Tsai, H., Yan, J., Wang, J., Liu, W. & Lin, R., 2018 Dec 1, In : Journal of Inflammation. 15, 1Research output: Contribution to journal › Article
5
Citations
(Scopus)
Anti-IL-20 monoclonal antibody inhibited inflammation and protected against cartilage destruction in murine models of osteoarthritis
Hsu, Y-H., Yang, Y. Y., Huwang, M. H., Weng, Y. H., Jou, I. M., Wu, P-T., Lin, T. Y., Wu, L-W. & Chang, M-S., 2017 Apr 1, In : PLoS ONE. 12, 4, e0175802.Research output: Contribution to journal › Article
osteoarthritis
Cartilage
interleukins
cartilage
Osteoarthritis
Anti-IL-20 monoclonal antibody inhibited tumor growth in hepatocellular carcinoma
Chiu, Y. S., Hsing, C. H., Li, C. F., Lee, C. Y., Hsu, Y-H. & Chang, M-S., 2017 Dec 1, In : Scientific reports. 7, 1, 17609.Research output: Contribution to journal › Article
Hepatocellular Carcinoma
Monoclonal Antibodies
Growth
Cyclin D1
Neoplasms
5
Citations
(Scopus)
IL-20 in rheumatoid arthritis
Hsu, Y-H. & Chang, M-S., 2017 Jun 1, In : Drug Discovery Today. 22, 6, p. 960-964 5 p.Research output: Contribution to journal › Review article
Rheumatoid Arthritis
Osteitis
Autoimmune Diseases
Joints
Clinical Trials
Thesis
The regulatory role of IL-29 on osteoblasts and osteoclasts
Author: 芳旭, 陳., 2018 Sep 1Supervisor: Hsu, Y. (Supervisor)
Student thesis: Master's Thesis
The role of IL-29 in adipocyte-macrophage crosstalk
Author: 恬毓, 林., 2017 Aug 18Supervisor: Hsu, Y. (Supervisor)
Student thesis: Master's Thesis